Postprandial Glucose Control Using the Medtronic Advanced Hybrid Closed-Loop System: Faster-Acting Insulin Aspart vs. Insulin Aspart

被引：1
|
作者：
Lee, Melissa H.
Vogrin, Sara
Paldus, Barbora
Morrison, Dale
Zaharieva, Dessi
Lu, Jean
Jones, Hannah
Wyatt, Sue A.
Netzer, Emma
Sims, Catriona M.
Macisaac, Richard
Grosman, Benyamin
Roy, Anirban
Kurtz, Natalie
Jenkins, Alicia
Oneal, David N.
机构：
来源：
DIABETES | 2020年 / 69卷
关键词：
D O I：
10.2337/db20-234-OR
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
234-OR
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Hybrid closed-loop glucose control with faster insulin aspart compared with standard insulin aspart in adults with type 1 diabetes: A double-blind, multicentre, multinational, randomized, crossover study
    Boughton, Charlotte K.
    Hartnell, Sara
    Thabit, Hood
    Poettler, Tina
    Herzig, David
    Wilinska, Malgorzata E.
    Ashcroft, Nicole L.
    Sibayan, Judy
    Cohen, Nathan
    Calhoun, Peter
    Bally, Lia
    Mader, Julia K.
    Evans, Mark
    Leelarathna, Lalantha
    Hovorka, Roman
    DIABETES OBESITY & METABOLISM, 2021, 23 (06): : 1389 - 1396
  • [32] EARLIER ONSET AND HIGHER EARLY EXPOSURE OF FASTER-ACTING INSULIN ASPART VS INSULIN ASPART IN ADULTS IS RETAINED IN CHILDREN AND ADOLESCENTS WITH T1D
    Danne, T.
    Biester, T.
    Fath, M.
    Rikte, T.
    Kordonouri, O.
    Haahr, H.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2016, 18 : A30 - A31
  • [33] Faster-acting insulin aspart vs insulin aspart as part of basal-bolus therapy improves postprandial glycaemic control in uncontrolled Type 2 diabetes in the double-blinded onset 2 trial
    Saravanan, P.
    Bowering, K.
    Case, C.
    Harvey, J.
    Reeves, M.
    Sampson, M.
    Strzinek, R.
    Bretler, D. M.
    Bang, R. B.
    Bode, B. W.
    DIABETIC MEDICINE, 2017, 34 : 21 - 21
  • [34] Double-Blind Mealtime Faster-Acting Insulin Aspart vs. Insulin Aspart in Basal-Bolus Improves Glycemic Control in T1D: The Onset® 1 Trial
    Russell-Jones, David
    Bode, Bruce W.
    De Block, Christophe
    Franek, Edward
    Heller, Simon R.
    Mathieu, Chantal
    Philis-Tsimikas, Athena
    Rose, Ludger
    Woo, Vincent C.
    Osterskov, Anne Birk
    Graungaard, Tina
    Bergenstal, Richard
    DIABETES, 2016, 65 : A77 - A77
  • [35] EARLIER ONSET OF EXPOSURE AND GREATER EARLY PHARMACOKINETIC AND PHARMACODYNAMIC EFFECTS FOR FASTER-ACTING INSULIN ASPART VERSUS INSULIN ASPART USING CONTINUOUS SUBCUTANEOUS INSULIN INFUSION
    Heise, T.
    Zijlstra, E.
    Rikte, T.
    Nosek, L.
    Haahr, H.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2016, 18 : A20 - A20
  • [36] Adding Faster-Acting Insulin Aspart to Basal Insulin Significantly Improved Glycemic Control: The Onset® 3 Trial
    Rodbard, Helena
    Tamer, Soren Can
    Velazquez, Maricela Vidrio
    Tripathy, Devjit
    Piletic, Milivoj
    Demissie, Marek
    DIABETES, 2016, 65 : A63 - A64
  • [37] Double-blind mealtime faster-acting insulin aspart vs insulin aspart in basal-bolus improves glycaemic control in Type 1 diabetes: the onset 1 trial
    Russell-Jones, D.
    Bode, B. W.
    De Block, C.
    Franek, E.
    Heller, S.
    Mathieu, C.
    Philis-Tsimikas, A.
    Rose, L.
    Woo, V.
    Osterskov, A. B.
    Graungaard, T.
    Bergenstal, R.
    DIABETIC MEDICINE, 2017, 34 : 8 - 8
  • [38] Copenfast trial: foetal growth and glycaemic control in pregnant women with type 1 or type 2 diabetes randomised to faster-acting insulin aspart or insulin aspart
    Norgaard, S.
    Soholm, J.
    Mathiesen, E.
    Norgaard, K.
    Clausen, T.
    Holmager, P.
    Do, N.
    Damm, P.
    Ringholm, L.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S122 - S122
  • [39] Pharmacokinetics of Faster and Standard Insulin Aspart During Fully Closed-Loop Insulin Delivery in Type 2 Diabetes
    Herzig, David
    Dehais, Joachim
    Prost, Jean-Christophe
    Nakas, Christos T.
    Stettler, Christoph
    Bally, Lia
    Hovorka, Roman
    DIABETES TECHNOLOGY & THERAPEUTICS, 2020, 22 (09) : 691 - 696
  • [40] Pharmacological properties of faster-acting insulin aspart vs insulin aspart in patients with type 1 diabetes receiving continuous subcutaneous insulin infusion: A randomized, double-blind, crossover trial
    Heise, Tim
    Zijlstra, Eric
    Nosek, Leszek
    Rikte, Tord
    Haahr, Hanne
    DIABETES OBESITY & METABOLISM, 2017, 19 (02): : 208 - 215
12345